PL161770B1 - Sposób wytwarzania srodka farmaceutycznego PL PL PL - Google Patents
Sposób wytwarzania srodka farmaceutycznego PL PL PLInfo
- Publication number
- PL161770B1 PL161770B1 PL29153087A PL29153087A PL161770B1 PL 161770 B1 PL161770 B1 PL 161770B1 PL 29153087 A PL29153087 A PL 29153087A PL 29153087 A PL29153087 A PL 29153087A PL 161770 B1 PL161770 B1 PL 161770B1
- Authority
- PL
- Poland
- Prior art keywords
- capsules
- capsule
- gelatin
- weight
- gelatin solution
- Prior art date
Links
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP61156954A JP2544113B2 (ja) | 1986-07-02 | 1986-07-02 | 安定なカプセル製剤 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL161770B1 true PL161770B1 (pl) | 1993-07-30 |
Family
ID=15638958
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL29153087A PL161770B1 (pl) | 1986-07-02 | 1987-07-01 | Sposób wytwarzania srodka farmaceutycznego PL PL PL |
Country Status (5)
| Country | Link |
|---|---|
| JP (1) | JP2544113B2 (de) |
| DD (2) | DD265406A5 (de) |
| PH (1) | PH25510A (de) |
| PL (1) | PL161770B1 (de) |
| ZA (1) | ZA874687B (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7413722B2 (en) | 2005-08-04 | 2008-08-19 | Foosung Co., Ltd. | Method and apparatus for manufacturing nitrogen trifluoride |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS4520800Y1 (de) * | 1966-08-02 | 1970-08-19 | ||
| JPS4823679U (de) * | 1971-07-26 | 1973-03-17 | ||
| JPS6078987A (ja) * | 1983-10-04 | 1985-05-04 | Shionogi & Co Ltd | アクリルアミドセフアロスポリン類 |
-
1986
- 1986-07-02 JP JP61156954A patent/JP2544113B2/ja not_active Expired - Lifetime
-
1987
- 1987-06-29 ZA ZA874687A patent/ZA874687B/xx unknown
- 1987-07-01 PL PL29153087A patent/PL161770B1/pl unknown
- 1987-07-02 DD DD87304539A patent/DD265406A5/de unknown
- 1987-07-02 DD DD32241987A patent/DD276031A5/de unknown
-
1989
- 1989-08-22 PH PH39122A patent/PH25510A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PH25510A (en) | 1991-07-24 |
| DD276031A5 (de) | 1990-02-14 |
| ZA874687B (de) | 1988-01-04 |
| JPS6314725A (ja) | 1988-01-21 |
| DD265406A5 (de) | 1989-03-01 |
| JP2544113B2 (ja) | 1996-10-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2019379706B2 (en) | Pharmaceutical composition comprising PARP inhibitors | |
| CA2552463C (en) | New compositions containing quinoline compounds | |
| CN101466379B (zh) | 稳定的拉喹莫德的制剂 | |
| AU2011279261B2 (en) | Formulations of rifaximin and uses thereof | |
| AU594167B2 (en) | A crystalline hydrate of oral cephalosporin and its composition | |
| RU2001115716A (ru) | Твердый фармацевтический препарат, содержащий ингибитор hmg-coa-редуктазы | |
| PL179534B1 (pl) | Sposób stabilizowania pranoprofenu i trwaly, ciekly preparat pranoprofenu PL PL PL PL PL PL | |
| JP2024033015A (ja) | 医薬品 | |
| AU2013221304B2 (en) | N-ethyl-N-phenyl-1,2-dihydro-4,5-di-hydroxy-1-methyl-2-oxo-3-quinoline carboxamide, preparation and uses thereof | |
| CN108938626A (zh) | 一种稳定性好和安全性高的卡络磺钠药物组合物及其制备方法和应用 | |
| IL99237A (en) | Preparation of a tablet or dragee composition containing a moisture-heat- and light-sensitive compounds having monoclinic crystalline structure | |
| US4837211A (en) | Spironolactone composition | |
| SI22750A (sl) | Ivabradin hidrobromid | |
| PL161770B1 (pl) | Sposób wytwarzania srodka farmaceutycznego PL PL PL | |
| JP2019196395A (ja) | 縮合アミノジヒドロチアジン誘導体の医薬組成物 | |
| EP0159777A1 (de) | Stabilisiertes 4-Carbamoyl-imidazolium-5-olat | |
| EP2043612B1 (de) | Stabile olanzapin-formulierung mit antioxidantien | |
| AU754138B2 (en) | Quinolinone derivative preparations and process for producing the same | |
| US4377583A (en) | N-Methyl-D-glucamine salt of with 3,4-dihydro-5-methyl-6-(2-methylpropyl)-4-oxothieno[2,3-d]pyrimidine-2-carboxylic acid | |
| JPH11322605A (ja) | ドパミン取り込み阻害剤含有製剤 | |
| JPS629096B2 (de) | ||
| JPS62258321A (ja) | 肝障害抑制剤 | |
| FI95349B (fi) | Menetelmä 7 -/(Z)-2-(2-aminotiatsol-4-yyli)-4-karboksibut-2-enoyyliamino/-3-kefeemi-4-karboksyylihappoa sisältävän gelatiinikapselin valmistamiseksi | |
| NO303264B1 (no) | FremgangsmÕte for fremstilling av et stabilt kapselpreparat | |
| JPS6033406B2 (ja) | アセチルサリチル酸系錠剤 |